Your browser doesn't support javascript.
loading
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC.
Bokhari, A A; Lai, W-Y; Le, A T; Gabre, J L; Chuang, T-P; Fransson, S; Bergman, B; Djos, A; Chen, N; Martinsson, T; Van den Eynden, J; Doebele, R C; Palmer, R H; Hallberg, B; Umapathy, G.
Afiliação
  • Bokhari AA; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Lai WY; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Le AT; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Gabre JL; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden; Department of Human Structure and Repair, Anatomy and Embryology Unit, Ghent University, 9000 Ghent, Belgium.
  • Chuang TP; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Fransson S; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Bergman B; Department of Respiratory Medicine, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden.
  • Djos A; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Chen N; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Martinsson T; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden.
  • Van den Eynden J; Department of Human Structure and Repair, Anatomy and Embryology Unit, Ghent University, 9000 Ghent, Belgium.
  • Doebele RC; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Palmer RH; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden. Electronic address: ruth.palmer@gu.se.
  • Hallberg B; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden. Electronic address: bengt.hallberg@gu.se.
  • Umapathy G; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-40530 Gothenburg, Sweden. Electronic address: ganesh.umapathy@gu.se.
Lung Cancer ; 171: 103-114, 2022 09.
Article em En | MEDLINE | ID: mdl-35933914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleosídeo Difosfato Redutase / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleosídeo Difosfato Redutase / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article